MAPK14 and atrial fibrillation: Notably, ALA/LA exerted protective effects through inhibition of reactive oxygen species generation, down-regulation of the activation of the p38 mitogen-activated protein kinase (MAPK) pathway, and the expression of transforming growth factor β1, which played a regulatory role in atrial fibrosis and contributed to the progression of AF [53].